Reduce unnecessary routine vitamin D testing (2024)

Can Fam Physician. 2023 Sep; 69(9): 620–622.

PMCID: PMC10498906

PMID: 37704241

Alexander G. Singer, MB BAO BCh CCFP

Associate Professor and Director of Research and Quality Improvement in the Department of Family Medicine at the University of Manitoba in Winnipeg and Director of the Manitoba Primary Care Research Network.

Christopher McChesney, MD

Resident in internal medicine at Western University in London, Ont, and was a summer student with Choosing Wisely Canada at the time this article was written.

Copyright and License information PMC Disclaimer

Cet article est disponible en français. Voyez "Réduire les dosages systématiques inutiles de la vitamine D".

Case introduction

Laura is a 40-year-old engineer of eastern European ancestry who presents to your office to request testing of her vitamin D levels. She generally wears sunscreen in the summer and wears sun-protective clothing year round. She is fairly healthy, eating a balanced diet high in fresh fruits and vegetables, but experiences migraines for which she takes triptans for rescue about 4 times per year. She and her partner own a house in a middle-class neighbourhood where they live with their son. Laura informs you that her mother has been taking vitamin D supplements for many years based on her doctor’s recommendations to improve her bone health. Additionally, Laura tells you that her neighbour, a nurse about her age, recently had her vitamin D levels checked and they were “very low,” so she has considered starting vitamin D supplementation.

Laura is hoping that by testing her vitamin D levels she will know how much supplementation she needs to take to protect her from COVID-19, cancer, and fractures as she gets older. Laura is worried that her levels might be low because she avoids direct sunlight and is concerned that she may be missing an easy opportunity to improve her health with supplementation she can afford.

In many family medicine practices, requests for tests by patients are a common occurrence. These requests might occur as part of visits about preventive health matters or be prompted by patient concerns. In the case of routine testing of vitamin D levels, literature suggests that it is driven by several factors, including media attention describing correlational studies connecting lack of vitamin D to various health concerns, and physicians promoting its use.1-10 During the height of the COVID-19 pandemic there were reports on studies that described associations between vitamin D deficiency and morbidity or mortality due to COVID-19 infection.11-14

Multiple evidence-synthesizing organizations, including Choosing Wisely Canada, Osteoporosis Canada, the United Kingdom (UK) National Institute for Health and Care Excellence, the Royal Australian College of General Practitioners, and the United States (US) Preventive Services Task Force, recommend against testing vitamin D levels in most patients. The reason for the similarity of these recommendations is the consistent evidence demonstrating that in healthy adults low vitamin D levels are not associated with any disease.13,15-21 Of importance, the US Preventive Services Task Force conducted a systematic review in 2021 that did not identify any studies that showed vitamin D screening improved health outcomes.18 The same study also did not find it caused any direct harms.

Costs and provider burden

For health systems focused on trying to achieve the Quadruple Aim,22 reducing vitamin D testing can be an achievable means to do so. Studies from the UK, the US, Canada, and Australia suggest that up to 75% of vitamin D testing may be unnecessary.9,23-27 Reductions in unnecessary vitamin D testing limit provider burden to follow up on results, do not impact patient experiences or outcomes, and improve the value of health care expenditures.

In many cases it is simpler to order a vitamin D test in response to a patient’s request; however, doing so may be potentially harmful to patients due to the unnecessary testing cascade that can follow an abnormal result.28 Additionally, because of the lack of evidence to support any kind of routine or follow-up vitamin D measurements, in some Canadian jurisdictions testing is no longer insured or even available without specific medical information, thus causing patients who may not be able to afford testing to incur a direct cost.29,30 Finally, health care budgets are not infinite and family physicians should be considerate of their role as stewards of this limited resource. The annual, not-insignificant cost of vitamin D testing is estimated to be approximately £17 million in the UK,31 A$104.7 million in Australia,32 $30 million in Canada,25 and $293 million (US) in the US.25

Unnecessary testing

Perhaps the most salient reason why routine vitamin D testing is unnecessary is that supplementation can be started regardless of blood levels. In fact, some guidelines continue to recommend vitamin D supplementation, particularly in northern climates such as Canada’s, regardless of blood levels.13,33 Vitamin D supplementation, particularly in northern climates and for patients with dark or pigmented skin, is still recommended by some guidelines despite any specific link to patient-oriented outcomes.13,18,34 In fact, a large randomized trial demonstrated supplemental vitamin D does not reduce the risk of fracture in older adults, even in those with low baseline levels or a previous fracture.35

Stewardship

Family physicians may be concerned that restricting testing in patients will negatively impact patient experience. However, there is strong evidence from stewardship efforts in primary care environments that patients are satisfied if they believe that the physician has listened to their concerns even if they did not receive a requested test.36-38 An approach to patients who request care that “seems unreasonable” by the Canadian Task Force on Preventive Health Care can be found in Figure 1.39

Open in a separate window

Figure 1.

Approach for when patients’ requests seem unreasonable

In a recent article in the BMJ, we outlined several practice-level strategies to support family physicians and health care system stakeholders who are interested in reducing vitamin D testing.40 Discussion support tools can assist family physicians with the difficult conversations that can occur regarding vitamin D testing if they are inclined not to order unnecessary testing.39,41,42 Sharing information allows patients and physicians to achieve a better understanding of health concerns and reach an agreement on goals.43 Moreover, requests for vitamin D testing can create opportunities for better patient engagement and moments to use shared decision-making skills.43

Box 1 is reproduced from our BMJ article and provides tips to help family physicians explore patient concerns that drive this type of request for testing.40 There are also several strategies outlined in our article on how to reduce unnecessary vitamin D testing using evidence-based approaches to quality improvement.40

Box 1.

Examples of questions and responses for a conversation with patients requesting vitamin D testing

Patient: “I would like a vitamin D level to test my status.”

Physician (options to respond):

  • “There is a lot of attention to vitamin D. What have you read or heard that leads you wonder about this?”

  • “I would like to understand what you are most concerned about that leads to your request.”

Patient: “I’ve heard that deficiency in vitamin D can cause [disease or concern].”

Physician (validation):

  • “Oh, I can understand your concern about [name it specifically].”

  • “Perhaps I can tell you more about that issue and we can then decide together whether you need a vitamin D level or not.”

Physician (information exchange—brief and avoid medical jargon):

  • Present key information about the patient’s specific concern; how we get vitamin D from sunlight or supplements; the high-risk groups that can be vitamin D deficient (indicating whether the patient is in any of these); and the best evidence about not testing but using supplementation

Physician (check in and respond to questions):

  • “What do you think of the information I presented? How does this fit for you?”

  • Address patient questions and come to a shared decision

Reproduced from McChesney et al.40

Case resolution

Upon further discussion with Laura regarding her interest in vitamin D testing, she reveals that a friend was recently diagnosed with cervical cancer and she had an uncle die from COVID-19. You review her chart and note that she is due for her cervical cancer screening, which can be done at a follow-up visit. You are able to reassure her that since she has been vaccinated against COVID-19 her risk of serious illness and death is substantially reduced and there is no evidence that vitamin D supplementation will impact her future risk. She remains interested in taking vitamin D in the winter since she can afford it, so you inform her that while it is not necessary, it has also not been shown to be harmful. At an upcoming practice meeting you suggest to your colleagues that they consider a practice audit of vitamin D testing and an education session to review current recommendations on the topic.

Conclusion

While vitamin D testing is mostly benign, it can harm patients by exposing them to unnecessary concern and testing cascades that can cause harm. It is important for family physicians to be active stewards of limited health resources, and illuminating unnecessary routine testing of vitamin D is a viable means to reduce health care costs with no evidence of impact on patient outcomes.

Acknowledgment

We thank Drs Wendy Levinson, Guylène Thériault, and Janet Reynolds for assistance with editing this manuscript.

Notes

Choosing Wisely Canada is a campaign designed to help clinicians and patients engage in conversations about unnecessary tests, treatments, and procedures and to help physicians and patients make smart and effective choices to ensure high-quality care is provided. To date there have been 13 family medicine recommendations, but many of the recommendations from other specialties are relevant to family medicine. Articles produced by Choosing Wisely Canada in Canadian Family Physician are on topics related to family practice where tools and strategies have been used to implement one of the recommendations and to engage in shared decision making with patients. If you are a primary care provider or trainee who has used Choosing Wisely recommendations or tools in your practice and you would like to share your experience, please contact us at gro.adanacylesiwgnisoohc@ofni.

Footnotes

Competing interests

None declared

This article is eligible for Mainpro+ certified Self-Learning credits. To earn credits, go to https://www.cfp.ca and click on the Mainpro+ link.

Cet article se trouve aussi en français à la page 623.

References

1. Bilinski K, Boyages S.. The rise and rise of vitamin D testing. BMJ2012;345:e4743. [PubMed] [Google Scholar]

2. Sattar N, Welsh P, Panarelli M, Forouhi NG.. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet2012;379(9811):95-6. [PubMed] [Google Scholar]

3. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al.. Vitamin D deficiency and risk of cardiovascular disease. Circulation2008;117(4):503-11. Epub 2008 Jan 7. [PMC free article] [PubMed] [Google Scholar]

4. Zipitis CS, Akobeng AK.. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child2008;93(6):512-7. Epub 2008 Mar 13. [PubMed] [Google Scholar]

5. Elvidge S.Can vitamin D help protect against COVID?Scientific American2021. Jun24. Available from: https://www.scientificamerican.com/article/can-vitamin-d-help-protect-against-covid. Accessed 2023 Aug 2.

6. Gallagher J.Vitamin D ‘heals damaged hearts’. BBC News2016. Apr4. Available from: https://www.bbc.com/news/health-35959556. Accessed 2023 Aug 2.

7. Relaxnews . Study links IBS to vitamin D deficiency. CTV News2015. Dec22. Available from: https://www.ctvnews.ca/health/study-links-ibs-to-vitamin-d-deficiency-1.2710385. Accessed 2023 Aug 2.

8. Huber CA, Nagler M, Rosemann T, Blozik E, Näpflin M, Markun S, et al.. Trends in micronutrient laboratory testing in Switzerland: a 7-year retrospective analysis of healthcare claims data. Int J Gen Med2020;13:1341-8. [PMC free article] [PubMed] [Google Scholar]

9. Rodd C, Sokoro A, Lix LM, Thorlacius L, Moffatt M, Slater J, et al.. Increased rates of 25-hydroxy vitamin D testing: dissecting a modern epidemic. Clin Biochem2018;59:56-61. Epub 2018 Jul 17. [PubMed] [Google Scholar]

10. Kolata G.Why are so many people popping vitamin D?The New York Times2017. Apr10. Available from: https://www.nytimes.com/2017/04/10/health/vitamin-d-deficiency-supplements.html. Accessed 2023 Aug 2.

11. Ali N.Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health2020;13(10):1373-80. Epub 2020 Jun 20. [PMC free article] [PubMed] [Google Scholar]

12. Pereira M, Dantas Damascena A, Galvão Azevedo LM, de Almeida Oliveira T, da Mota Santana J.. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr2022;62(5):1308-16. Epub 2020 Nov 4. Addendum in: Crit Rev Food Sci Nutr 2023;63(4):557-62. Epub 2021 Aug 12. [PubMed] [Google Scholar]

13. COVID-19 rapid guideline: vitamin D. London, UK: National Institute for Health and Care Excellence; 2020. Available from: https://www.nice.org.uk/guidance/ng187/resources/covid19-rapid-guideline-vitamin-d-pdf-66142026720709. Accessed 2023 Aug 2. [PubMed] [Google Scholar]

14. Dunham J.More than 80 per cent of hospitalized COVID-19 patients had vitamin D deficiency: study. CTV News2020. Oct27. Available from: https://www.ctvnews.ca/health/more-than-80-per-cent-of-hospitalized-covid-19-patients-had-vitamin-d-deficiency-study-1.5162396. Accessed 2023 Aug 3.

15. Medical Advisory Secretariat . Clinical utility of vitamin D testing: an evidence-based analysis. Ont Health Technol Assess Ser2010;10(2):1-93. Epub 2010 Feb 1. [PMC free article] [PubMed] [Google Scholar]

16. Francis R, Aspray T, Fraser W, Macdonald H, Patel S, Mavroeidi A, et al.. Vitamin D and bone health: a practical clinical guideline for patient management. Bath, UK: Royal Osteoporosis Society; 2018. Available from: https://strwebprdmedia.blob.core.windows.net/media/ef2ideu2/ros-vitamin-d-and-bone-health-in-adults-february-2020.pdf. Accessed 2023 Aug 3. [Google Scholar]

17. Arundel P, Shaw N.. Vitamin D and bone health: a practical clinical guideline for patient management in children and young people. Bath, UK: Royal Osteoporosis Society; 2018. Available from: https://theros.org.uk/media/54vpzzaa/ros-vitamin-d-and-bone-health-in-children-november-2018.pdf. Accessed 2023 Aug 3. [Google Scholar]

18. Kahwati LC, LeBlanc E, Weber RP, Giger K, Clark R, Suvada K, et al.. Screening for vitamin D deficiency in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA2021;325(14):1443-63. [PubMed] [Google Scholar]

19. Guidelines for preventive activities in general practice. 9th ed.East Melbourne, Aust: Royal Australian College of General Practitioners; 2018. Available from: https://www.racgp.org.au/FSDEDEV/media/documents/Clinical%20Resources/Guidelines/Red%20Book/Guidelines-for-preventive-activities-in-general-practice.pdf. Accessed 2023 Aug 3. [Google Scholar]

20. Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD, Cole DEC, et al.. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ2010;182(12):E610-8. Epub 2010 Jul 12. [PMC free article] [PubMed] [Google Scholar]

21. College of Family Physicians of Canada . Thirteen tests and treatments to question. Toronto, ON: Choosing Wisely Canada; 2023. Available from: https://choosingwiselycanada.org/family-medicine. Accessed 2023 Aug 3. [Google Scholar]

22. Bodenheimer T, Sinsky C.. From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med2014;12(6):573-6. [PMC free article] [PubMed] [Google Scholar]

23. Woodford HJ, Barrett S, Pattman S.. Vitamin D: too much testing and treating?Clin Med (Lond)2018;18(3):196-200. [PMC free article] [PubMed] [Google Scholar]

24. Gonzalez-Chica D, Stocks N.. Changes to the frequency and appropriateness of vitamin D testing after the introduction of new Medicare criteria for rebates in Australian general practice: evidence from 1.5 million patients in the NPS MedicineInsight database. BMJ Open2019;9(3):e024797. [PMC free article] [PubMed] [Google Scholar]

25. Morgen EK, Naugler C.. Inappropriate repeats of six common tests in a Canadian city: a population cohort study within a laboratory informatics framework. Am J Clin Pathol2015;144(5):704-12. [PubMed] [Google Scholar]

26. Boyages SC.Vitamin D testing: new targeted guidelines stem the overtesting tide. Med J Aust2016;204(1):18. [PubMed] [Google Scholar]

27. Crowe FL, Jolly K, MacArthur C, Manaseki-Holland S, Gittoes N, Hewison M, et al.. Trends in the incidence of testing for vitamin D deficiency in primary care in the UK: a retrospective analysis of The Health Improvement Network (THIN), 2005-2015. BMJ Open2019;9(6):e028355. [PMC free article] [PubMed] [Google Scholar]

28. Rockwell MS, Wu YX, Salamoun M, Hulver MW, Epling JW.. Patterns of clinical care subsequent to nonindicated vitamin D testing in primary care. J Am Board Fam Med2020;33(4):569-79. [PubMed] [Google Scholar]

29. Naugler C, Hemmelgarn B, Quan H, Clement F, Sajobi T, Thomas R, et al.. Implementation of an intervention to reduce population-based screening for vitamin D deficiency: a cross-sectional study. CMAJ Open2017;5(1):E36-9. [PMC free article] [PubMed] [Google Scholar]

30. Chami N, Li Y, Weir S, Wright JG, Kantarevic J.. Effect of strict and soft policy interventions on laboratory diagnostic testing in Ontario, Canada: a Bayesian structural time series analysis. Health Policy2021;125(2):254-60. Epub 2020 Oct 24. [PubMed] [Google Scholar]

31. Bolland MJ, Avenell A, Smith K, Witham MD, Grey A.. Vitamin D supplementation and testing in the UK: costly but ineffective?BMJ2021;372:n484. [PubMed] [Google Scholar]

32. Gordon L, Waterhouse M, Reid IR, Neale RE.. The vitamin D testing rate is again rising, despite new MBS testing criteria. Med J Aust2020;213(4):155-155.e1. Epub 2020 May 20. [PubMed] [Google Scholar]

33. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al.. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab2011;96(7):1911-30. Epub 2011 Jun 6. Erratum in: J Clin Endocrinol Metab 2011;96(12):3908. [PubMed] [Google Scholar]

34. Position statement: use and interpretation of vitamin D testing. Surry Hills, Aust: Royal College of Pathologists of Australasia; 2019. Available from: https://www.rcpa.edu.au/Library/College-Policies/Position-Statements/Use-and-Interpretation-of-Vitamin-D-Testing. Accessed 2023 Aug 3. [Google Scholar]

35. LeBoff MS, Chou SH, Ratliff KA, Cook NR, Khurana B, Kim E, et al.. Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med2022;387(4):299-309. [PMC free article] [PubMed] [Google Scholar]

36. Coronado-Vázquez V, Canet-Fajas C, Delgado-Marroquín MT, Magallón-Botaya R, Romero-Martín M, Gómez-Salgado J.. Interventions to facilitate shared decision-making using decision aids with patients in primary health care: a systematic review. Medicine (Baltimore)2020;99(32):e21389. [PMC free article] [PubMed] [Google Scholar]

37. Joosten EA, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CPF, de Jong CAJ.. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom2008;77(4):219-26. Epub 2008 Apr 16. [PubMed] [Google Scholar]

38. Stacey D, Légaré F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al.. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev2017;(4):CD001431. [PMC free article] [PubMed] [Google Scholar]

39. Thériault G, Grad R, Dickinson JA, Breault P, Singh H, Bell NR, et al.. To share or not to share. When is shared decision making the best option?Can Fam Physician2020;66:327-31 (Eng), e149-54 (Fr). [PMC free article] [PubMed] [Google Scholar]

40. McChesney C, Singer A, Duquette D, Forouhi NG, Levinson W.. Do not routinely test for vitamin D. BMJ2022;378:e070270. [PubMed] [Google Scholar]

41. Stiggelbout AM, Van der Weijden T, De Wit MPT, Frosch D, Légaré F, Montori VM, et al.. Shared decision making: really putting patients at the centre of healthcare. BMJ2012;344:e256. Erratum in: BMJ 2012;344:e863. [PubMed] [Google Scholar]

42. Légaré F, Adekpedjou R, Stacey D, Turcotte S, Kryworuchko J, Graham ID, et al.. Interventions for increasing the use of shared decision making by healthcare professionals. Cochrane Database Syst Rev2018;(7):CD006732. [PMC free article] [PubMed] [Google Scholar]

43. Abrams EM, Shaker M, Oppenheimer J, Davis RS, Bukstein DA, Greenhawt M.. The challenges and opportunities for shared decision making highlighted by COVID-19. J Allergy Clin Immunol Pract2020;8(8):2474-80.e1. Epub 2020 Jul 14. [PMC free article] [PubMed] [Google Scholar]

Reduce unnecessary routine vitamin D testing (2024)
Top Articles
Latest Posts
Article information

Author: Lilliana Bartoletti

Last Updated:

Views: 6059

Rating: 4.2 / 5 (73 voted)

Reviews: 80% of readers found this page helpful

Author information

Name: Lilliana Bartoletti

Birthday: 1999-11-18

Address: 58866 Tricia Spurs, North Melvinberg, HI 91346-3774

Phone: +50616620367928

Job: Real-Estate Liaison

Hobby: Graffiti, Astronomy, Handball, Magic, Origami, Fashion, Foreign language learning

Introduction: My name is Lilliana Bartoletti, I am a adventurous, pleasant, shiny, beautiful, handsome, zealous, tasty person who loves writing and wants to share my knowledge and understanding with you.